EUVIMEDEUVIMED entdecken
Crossref

Detection of clinically actionable gene fusions by next‐generation sequencing‐based RNA sequencing of non–small cell lung cancer cytology specimens: A single‐center experience with comparison to fluorescence in situ hybridization

John Diks iD, Zhenya Tang, Mehmet Altan, Sarah Anderson, Hui Chen, Asif Rashid, Richard Kenneth Yang, Mark J Routbort, Keyur P Patel, Gokce A Toruner, L Jeffrey Medeiros, Guilin Tang und 2 weitere

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von John Diks und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genomic profiling is needed to identify actionable alterations in non–small cell lung cancer (NSCLC). Panel‐based testing such as next‐generation sequencing (NGS) is often preferred to interrogate multiple alterations simultaneously. In this study, we evaluate the utility of an RNA‐based NGS assay to detect genomic alterations in NSCLC cytology specimens and compare these results to fluorescence in situ hybridization (FISH) testing.

Methods

A retrospective review was performed of 264 NSCLC cytology specimens that were concurrently tested for gene fusions by RNA‐based NGS and ALK , RET , and/or ROS1 by FISH.

Results

Genomic alterations were detected in 29 cases by NGS, including ALK , RET , ROS1 , NTRK , NUTM1 , and FGFR3 fusions and MET exon 14 skipping alterations. Of the 20 cases with ALK , RET , and ROS1 fusions detected by NGS, 16 (80%) were concordant with the corresponding FISH results. Three cases showed discordance, where EML4::ALK ( n = 2) and SLC34A2::ROS1 ( n = 1) fusions were not detected by the corresponding FISH assay; one case with EZR::ROS1 was inadequate for FISH. No gene fusions were detected in 181 cases by NGS and 54 cases failed testing. The concordance rates for detecting ALK , RET , and ROS1 fusions using NGS and FISH were 97%, 100%, and 99.5%, respectively.

Conclusion

RNA‐based NGS can be used to detect gene fusions in NSCLC cytology cases with high concordance with FISH results. However, RNA‐based NGS may have high failure rates and therefore a low threshold for reflexing inadequate cases to an orthogonal testing method is essential for comprehensive genomic profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansProtein-Tyrosine KinasesAnaplastic Lymphoma KinaseRNAIn Situ Hybridization, FluorescenceProto-Oncogene ProteinsHigh-Throughput Nucleotide SequencingGene FusionSequence Analysis, RNAGene Rearrangement

Stichwörter der Autor:innen

comprehensive genomic profiling (CGP)cytology specimensfluorescence in situ hybridization (FISH)gene fusionsnext-generation sequencingnon-small cell lung cancer

Substanzen

Protein-Tyrosine KinasesAnaplastic Lymphoma KinaseRNAProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: John Diks, Sinchita Roy-Chowdhuri

Zitieren

APA

Diks, J., Tang, Z., Altan, M., Anderson, S., Chen, H., Rashid, A., Yang, R. K., Routbort, M. J., Patel, K. P., Toruner, G. A., Medeiros, L. J., Tang, G., Luthra, R., & Roy-Chowdhuri, S. (2024). Detection of clinically actionable gene fusions by next‐generation sequencing‐based RNA sequencing of non–small cell lung cancer cytology specimens: A single‐center experience with comparison to fluorescence in situ hybridization. Cancer Cytopathology. https://doi.org/10.1002/cncy.22766

Vancouver

Diks J, Tang Z, Altan M, Anderson S, Chen H, Rashid A, et al. Detection of clinically actionable gene fusions by next‐generation sequencing‐based RNA sequencing of non–small cell lung cancer cytology specimens: A single‐center experience with comparison to fluorescence in situ hybridization. Cancer Cytopathology. 2024. doi:10.1002/cncy.22766

BibTeX
@article{Diks2024,
  author = {Diks, John and Tang, Zhenya and Altan, Mehmet and Anderson, Sarah and Chen, Hui and Rashid, Asif and Yang, Richard Kenneth and Routbort, Mark J and Patel, Keyur P and Toruner, Gokce A and Medeiros, L Jeffrey and Tang, Guilin and Luthra, Rajyalakshmi and Roy-Chowdhuri, Sinchita},
  title = {Detection of clinically actionable gene fusions by next‐generation sequencing‐based RNA sequencing of non–small cell lung cancer cytology specimens: A single‐center experience with comparison to fluorescence in situ hybridization},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22766}
}
Kostenlos starten →